HitIQ Limited (AU:HIQ)
ASX:HIQ
Want to see AU:HIQ full AI Analyst Report?
HIQ Stock Chart & Stats
AU$0.02
AU$0.00(0.00%)
At close: 4:00 PM EST
AU$0.02
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$0.01 - AU$0.04
Previous CloseN/A
Volume134.14K
Average Volume (3M)233.78K
Market Cap
AU$9.83M
Enterprise ValueAU$7.12M
Total Cash (Recent Filing)AU$359.17K
Total Debt (Recent Filing)AU$1.53M
Price to Earnings (P/E)―
Beta0.27
Next Earnings
Aug 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding756,219,300
10 Day Avg. Volume147,164
30 Day Avg. Volume233,782
Financial Highlights & Ratios
PEG Ratio-0.01
Price to Book (P/B)-1.60
Price to Sales (P/S)3.20
P/FCF Ratio-1.38
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Recurring Hardware + Software ModelHitIQ combines instrumented mouthguards with subscription analytics, creating a mixed hardware plus recurring software revenue model. This structure supports longer-term, predictable revenue, higher lifetime value per customer, and recurring service relationships that aid retention and upsell over multiple seasons.
Specialized Head-impact Product And AnalyticsThe company offers a focused, niche solution for head-impact monitoring—instrumented mouthguards plus analytics—aligning with growing sports safety and performance needs. Specialization supports defensibility, deep domain expertise, and stickier customer relationships with teams and leagues focused on athlete welfare.
Relative Cash Efficiency (FCF To Net Income)Although absolute cash flows are negative, an FCF-to-net-income ratio ~1.0 signals discipline in converting accounting losses into free cash flow. This suggests controlled capex and potential operational efficiency levers that can extend runway while management pursues commercialization and recurring revenue growth.
Bears Say
Weak Balance Sheet / Negative EquityThe balance sheet shows negative shareholders' equity and a -1.41 debt-to-equity metric, indicating capital structure stress. This constrains financial flexibility, increases refinancing or dilution risk, and limits capacity to fund product development, sales scaling, or absorb demand shocks without external capital.
Severely Negative Profit MarginsExtremely negative gross and net margins imply the current cost structure and pricing do not cover direct costs and overhead. Persistent margin deficits undermine free-cash-generation potential, require structural cost reductions or pricing changes, and pose a material barrier to reaching sustainable profitability.
Negative Operating And Free Cash FlowsOperating and free cash flows are negative, meaning the business currently burns cash to run operations and invest. Continued cash burn increases dependence on external financing, risks interruptions to customer programs, and can limit investments in sales, R&D, or service support needed for long-term growth.
HitIQ Limited News
HIQ FAQ
What was HitIQ Limited’s price range in the past 12 months?
HitIQ Limited lowest share price was AU$0.01 and its highest was AU$0.04 in the past 12 months.
What is HitIQ Limited’s market cap?
HitIQ Limited’s market cap is AU$9.83M.
When is HitIQ Limited’s upcoming earnings report date?
HitIQ Limited’s upcoming earnings report date is Aug 27, 2026 which is in 118 days.
How were HitIQ Limited’s earnings last quarter?
HitIQ Limited released its earnings results on Feb 26, 2026. The company reported -AU$0.006 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.006.
Is HitIQ Limited overvalued?
According to Wall Street analysts HitIQ Limited’s price is currently Overvalued.
Does HitIQ Limited pay dividends?
HitIQ Limited does not currently pay dividends.
What is HitIQ Limited’s EPS estimate?
HitIQ Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does HitIQ Limited have?
HitIQ Limited has 756,219,300 shares outstanding.
What happened to HitIQ Limited’s price movement after its last earnings report?
HitIQ Limited reported an EPS of -AU$0.006 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 7.143%.
Which hedge fund is a major shareholder of HitIQ Limited?
Currently, no hedge funds are holding shares in AU:HIQ
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
HitIQ Limited Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:HIQ Sentiment 100%
Sector Average 72%
Sector Average 72%
Insider Transactions
Bought Shares
Worth AU$22.5K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bearish
Bullish news 0%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-19.23%
12-Months-Change
Fundamentals
Return on Equity
152.58%
Trailing 12-Months
Asset Growth
-61.76%
Trailing 12-Months
Company Description
HitIQ Limited
HitIQ Limited engages in development and commercialization of concussion management technology in Australia. Its Nexus software provides comprehensive head impact data and analysis to make informed decisions to improve the quality of care for athletes. It also offers CoVR, a virtual reality based cognitive and oculomotor assessment platform, which identifies impairments across domains, such as hand-eye coordination, memory, and decision making; and CSX that provides an easy to use, sideline concussion assessment tool, which produces a digital record that can be shared with medical professionals, family, and organizations to take coordinated athlete care. The company was incorporated in 2015 and is based in Melbourne, Australia.
Technical Analysis
Resonance Health Ltd
―
Global Health Limited
―
Singular Health Group Ltd
―
Emyria Ltd
―
InteliCare Holdings Limited
―
Options Prices
Currently, No data available
---